New kind of contraceptive pills could halve the risk of ovarian cancer in young women

NEWER contraceptive pills may halve the risk of ovarian cancer in young women, a study says.

It suggests combined tablets, containing lower doses of oestrogens and newer-generation progestogens, have a positive effect, docs in Aberdeen and Copenhagen revealed.

1

Women who use newer oral contraceptives and other hormonal contraceptive methods also want to know whether they are likely to experience the same benefit.

Researchers at the University of Aberdeen and the University of Copenhagen investigated the influence of newer hormonal contraceptives - combined and progestogen-only products - on overall and specific types of ovarian cancer in women of reproductive age.

Study author Dr Lisa Iversen, a Research Fellow at Aberdeen University, said: "Based on our results, contemporary combined hormonal contraceptives are still associated with a reduced risk of ovarian cancer in women of reproductive age, with patterns similar to those seen with older combined oral products."

MOST READ IN HEALTH NEWS

SPECIAL OPS

Soldier saves sick pal's life by donating a kidney after he collapsed

ALLERGY HORROR

Girl, 18, ‘died on mum’s shoulder’ after reaction to chicken and chips

PIERS MORGAN

Maybe now teens will see the 'Body Positivity' delusion for what it really is

WARD A RESULT!

The NHS hospital with no backlog and treats more patients than before Covid

She added: "The reduced risk seems to persist after stopping use, although the duration of benefit is uncertain.

"Presently, there is insufficient evidence to suggest similar protection among exclusive users of progestogen-only products."

The researchers said that it was an observational study, so no firm conclusions can be drawn about cause and effect - but they do support the findings of studies of older products.

• GOT a story? Ring The Sun on 0207 782 4104 or WHATSAPP on 07423720250 or email [email protected].